ethyl-α-D-arabinofuranoside | 64949-97-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: ethyl-α-D-arabinofuranoside
• 英文别名: Aethyl-α-D-arabinofuranosid；(2S,3S,4S,5R)-2-ethoxy-5-(hydroxymethyl)oxolane-3,4-diol
• CAS: 64949-97-9
• 化学式: C₇H₁₄O₅
• 分子量: 178.185
• InChiKey: XESKOQZTIQOBMT-JWXFUTCRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.2
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  79.2
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• Enzyme-directed immunostimulant and uses thereof
  申请人：Washington State University

  公开号：US11117918B2

  公开（公告）日：2021-09-14

  The disclosed invention relates to the novel composition of matter that allows for the controlled release of highly active compounds to be delivered to a desired site. This novel composition utilizes the immune system to allow for the controlled release of desired compounds. The present invention can utilize a plurality of highly active compounds, with one embodiment being the use of chemotherapeutics for the treatment of cancer.

  本发明涉及一种新型物质组合物，它可以控制高活性化合物的释放，将其输送到所需的部位。这种新型组合物利用免疫系统来控制所需化合物的释放。本发明可利用多种高活性化合物，其中一个实施方案是使用化疗药物治疗癌症。
• ONE STEP ENZYMATIC PROCESS FOR PRODUCING ALKYL FURANOSIDES
  申请人：Ecole Nationale Supérieure de Chimie de Rennes

  公开号：EP2841587A1

  公开（公告）日：2015-03-04
• ENZYME-DIRECTED IMMUNOSTIMULANT AND USES THEREOF
  申请人：Washington State University

  公开号：US20200199166A1

  公开（公告）日：2020-06-25

  The disclosed invention relates to the novel composition of matter that allows for the controlled release of highly active compounds to be delivered to a desired site. This novel composition utilizes the immune system to allow for the controlled release of desired compounds. The present invention can utilize a plurality of highly active compounds, with one embodiment being the use of chemotherapeutics for the treatment of cancer.
• [EN] ONE STEP ENZYMATIC PROCESS FOR PRODUCING ALKYL FURANOSIDES<br/>[FR] PROCÉDÉ ENZYMATIQUE À UNE ÉTAPE POUR LA FABRICATION D'ALKYL FURANOSIDES
  申请人：ENSCR

  公开号：WO2013160205A1

  公开（公告）日：2013-10-31

  The present invention relates to a process for enzymatically converting a furanoside substrate in a product of interest, comprising contacting said substrate with an enzyme in presence of an alcohol acceptor, wherein said enzyme is preferably Araf51, and wherein said product is preferably an alkyl furanoside. The present invention also relates to mutant Araf51 enzyme showing improved transglycosylation activity in comparison with the native wild-type (wt) Araf51 enzyme, and to a method for screening said mutants.